Dexlansoprazole Modified Release Capsules 30 MG - LANSODEX 30 Capsules

LANSODEX 30 Capsules – Dual Delayed Release for Sustained Acid Control.

LANSODEX 30 Capsules – The composition of Dexlansoprazole Modified Release Capsules 30 MG is an advanced proton pump inhibitor (PPI) designed with Dual Delayed-Release (DDR) technology for sustained acid suppression. It works by irreversibly inhibiting the H⁺/K⁺ ATPase enzyme in gastric parietal cells, reducing acid production. Its extended-release profile ensures long-lasting control of both daytime and night-time GERD symptoms.

Key Benefits of Dexlansoprazole Modified Release – LANSODEX 30 Capsules
✅ Dual Delayed-Release (DDR) Technology – Provides two distinct releases of Dexlansoprazole for extended acid suppression, ensuring prolonged symptom control for up to 24 hours.
✅ Superior Night-time Symptom Relief – More effective than conventional PPIs in managing nocturnal acid breakthrough and improving sleep quality in GERD patients.
✅ Flexible Dosing with or without Food – Unique formulation allows administration regardless of meals, improving patient compliance and convenience.

Recommended By Specialists:
👨‍⚕️ Gastroenterologists: Mainly prefer this combination to treat gastroesophageal reflux disease (GERD), erosive esophagitis, and nonerosive GERD (NERD).
👨‍⚕️ General Physicians: Commonly used for patients with frequent or persistent GERD symptoms, offering a once-daily dosing regimen that enhances patient compliance.

INDICATIONS:
✅ Gastroesophageal Reflux Disease (GERD)
✅ Erosive Esophagitis
✅ Non-Erosive Reflux Disease (NERD)
✅ Maintenance Therapy for GERD
✅ Acid-related Dyspepsia